Droperidol vs haloperidol
Economic: direct costs · acute psychosis
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Findings
What do systematic reviews say?
7 questions · 7 findings · 3 reviews · Schizophrenia
No studies found 2 · 28.6%GRADE not reported 5 · 71.4%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Droperidol vs midazolam
Economic: direct costs · acute psychosis
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Droperidol vs OLANZAPINE
Economic: direct costs · acute psychosis
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Droperidol vs placebo
Economic: direct costs · acute psychosis
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
α‐FLUPENTHIXOL vs PLACEBO or β‐FLUPENTHIXOL
Economic: direct costs · patients with schizophrenia
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Peer support plus standard care vs clinician‐led support plus standard care
Economic: indirect costs (cost to society) · people with schizophrenia or other serious mental illness
The review found no eligible studies for this question.
1 finding from 1 review
- Peer support for people with schizophrenia or other serious mental illness 2019 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Peer support plus standard care vs usual care
Economic: indirect costs (cost to society) · people with schizophrenia or other serious mental illness
The review found no eligible studies for this question.
1 finding from 1 review
- Peer support for people with schizophrenia or other serious mental illness 2019 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found